Business
Bill Ackman, in his obsessive, Ahab-like quest to force Botox-maker Allergan (AGN) to acquiesce to a hostile $54 billion takeover bid from Valeant (VRX),...
Hi, what are you looking for?
Bill Ackman, in his obsessive, Ahab-like quest to force Botox-maker Allergan (AGN) to acquiesce to a hostile $54 billion takeover bid from Valeant (VRX),...
Allergan (AGN), desperately avoiding a hostile takeover bid from Valeant (VRX), which was spurred on by pitbull … er … hedge fund manager Bill...
– Allergan’s newest strategy to fend off a $51 billion hostile takeover bid from Valeant Pharmaceuticals involves filing a suit in a California...